prohibition partners
prohibition partners · page 8
- News
Cannabis Is Now A Compelling Opportunity For The Main Tobacco Companies
International cannabis expert, Barbara Pastori, of Prohibition Partners shares her thoughts on why cannabis is a compelling opportunity for the main tobacco companies.
- Pharmaceutical
Sales Of Three Major Pharmaceutical Cannabis Products Set To Reach €1.8 Billion By 2025
COMBINED sales of the three most lucrative cannabis pharmaceuticals products – Epidiolex, Dronabinol and Sativex – are set to reach €1.8 billion by 2025, according to a new report.
- News
Prohibition Partners Creates Largest Global Cannabis Audience With North American Purchase
LEADING UK business Prohibition Holdings – parent company of global data and canna-tech firm Prohibition Partners – has acquired North American media platform Business of Cannabis in a share-based transaction creating the biggest global cannabis B2B group.
- Adult-Use
Prohibition Partners Acquires Business of Cannabis
Acquisition of North American Publisher Creates the Leading B2B Media & Data Platform in Global Cannabis London, United Kingdom, August 4, 2021 – Prohibition Holdings Ltd (parent company of Prohibition Partners) today announces its 100% acquisition of Business of Cannabis to form the industry’s new leader in media and data as well as the largest…
- Adult-Use
Extraction Emerging As One Of the Most Lucrative Cannabis Industry Verticals, Finds New Report
THE emerging extraction industry is proving to be one of the most active areas of innovation and growth in the cannabis industry, finds a new in-depth report from Prohibition Partners.
- News
US Senate Bill On Federal Cannabis Legalisation Receives Widespread Support
By Conor O’Brien, Analyst, Prohibition Partners ON Wednesday, 14 July, Senate Majority Leader Chuck Schumer released a draft bill that would federally legalise cannabis in the US.
- Adult-Use
Adult-Use Cannabis Legalisation in Europe? It’s Coming Faster Than You May Think
By Barbara Pastori ADULT-USE cannabis legalisation is picking up pace in the Americas.
- Pharmaceutical
Industry Concerns Surface Over No 10 Taskforce’s Hemp And Cannabis Proposals
THE initial warm welcome to proposals to make UK cannabinoid regulations a matter for the health authorities – not the criminal ones – have cooled in recent days.
- Pharmaceutical
New Era Beckons For Swiss Medical Cannabis Patients After Ten Years In Slow Lane
THE impending change to Switzerland’s medical cannabis laws could see the number of patients receiving treatment rise from 3,000 a year to over 100,000 by 2023.
- Adult-Use
‘Science And Economics’ Will Forge A European Path To End Prohibition
SCIENCE and economics will win the day allowing cannabis to move from the illicit to legal-regulated markets across Europe, says the head of the world’s largest cannabis company.
- Medical
Covid Vaccines Highlight How Real-World Data Could Be Used In Cannabis Medicine
THE medical profession must learn from the way Covid-19 vaccines have been subjected to real-world efficacy trials – and adopt a similar pathway for cannabis, says one of the UK’s leading cannabis practitioners.
- Pharmaceutical
Over 1,500 Attendees For PPLive As Appetite For Cannabis Investment Soars
PROHIBITION PARTNERS Live makes its third appearance tomorrow and over the course of three days will feature dozens of virtual discussions and debates showcasing the rapid development of the global cannabis industry.
